Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation
Open Access
- 1 June 2015
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 11 (9) , 1458-1473
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA128814)
- Melanoma Research Foundation
This publication has 46 references indexed in Scilit:
- The UPs and DOWNs of MITF in melanoma resistance.Pigment Cell & Melanoma Research, 2014
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanomaNature Communications, 2014
- Oncogene Mimicry as a Mechanism of Primary Resistance to BRAF InhibitorsCell Reports, 2014
- Adaptive resistance to RAF inhibitors in melanomaPigment Cell & Melanoma Research, 2014
- Siah2 regulates tight junction integrity and cell polarity through control of ASPP2 stabilityOncogene, 2013
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- Mutations of the BRAF gene in human cancerNature, 2002
- Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormoneNature, 1997
- Involvement of Janus Kinases in the Insulin Signaling PathwayEuropean Journal of Biochemistry, 1995
- Interactions of Cbl with Grb2 and Phosphatidylinositol 3′-Kinase in Activated Jurkat CellsMolecular and Cellular Biology, 1995